Noninvasive preimplantation genetic testing for aneuploidies (NiPGT-A) and the principle of primum non nocere

0Citations
Citations of this article
21Readers
Mendeley users who have this article in their library.

Abstract

Perhaps with the intention of obtaining larger amounts of free-DNA, some groups are routinely postponing and establishing free-DNA collection in culture medium for Noninvasive preimplantation genetic testing for aneuploidies (niPGT-A) to day 6 for all blastocysts. A meta-analysis served as the basis for such decision, since statistically similar live birth rates were observed when the transfers of euploid blastocysts were performed on day 5 versus day 6 However, the euploidy analysis was conducted in only two studies However, after including the two more studies we performed a new meta-analysis that clearly showed the risks of losing live births with the decision of adopting the 6th day as the endpoint for gathering free-DNA. We would be losing 1.71x more live births.

Cite

CITATION STYLE

APA

Franco, J. G., Dieamant, F., & Oliveira, J. B. A. (2020). Noninvasive preimplantation genetic testing for aneuploidies (NiPGT-A) and the principle of primum non nocere. Jornal Brasileiro de Reproducao Assistida. SBRA - Associação Brasileira de Reprodução Assistida (Brazilian Society of Assisted Reproduction). https://doi.org/10.5935/1518-0557.20200075

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free